the us epa reversed itself on microplastics and pharmaceuticals in drinking water: after announcing in april they would be added to the mandatory contaminants list, it excluded them from the testing program in late june, citing undeveloped test methods. a regulatory position flipping within roughly two months, against the direction of its own prior announcement and public pressure, is an unusual institutional reversal on a public-health question.